Anti-Human CLPTM1L Recombinant Antibody (SAA1885) (HA064013)

Name: Anti-Human CLPTM1L Recombinant Antibody (SAA1885)
Brand: abinScience
SKU: HA064013
Price: 196 USD
Availability: InStock

Datasheet Share product Copy info

Price(USD):

Spec:

50ug
100ug
1mg

Number:

Get quote

Overview
Images
References
Datasheet
SDS

Overview

Catalog No.

HA064013

Species reactivity

Human

Applications

ELISA

Host species

Mouse

Isotype

IgG2a, kappa

Clone ID

SAA1885

Clonality

Monoclonal

Target

CRR9p, CLPTM1L, CRR9, Cisplatin resistance-related protein 9, CLPTM1-like protein, Cleft lip and palate transmembrane protein 1-like protein

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q96KA5

RRID

Anti-Human CLPTM1L Antibody (SAA1885) (abinScience Cat# HA064013, RRID:AB_3727649)
_x005F_x005F_x000D_

Form

Liquid

Storage buffer

0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Product Usage Information

Application	Dilution
ELISA	1:2000-1:20000

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Background

Lipid scramblase CLPTM1L is a ~62 kDa protein. Scramblase that mediates the translocation of glucosaminylphosphatidylinositol (alpha-D-GlcN-(1-6)-(1,2-diacyl-sn-glycero-3-phospho)-1D-myo-inositol, GlcN-PI) across the endoplasmic reticulum (ER) membrane, from the cytosolic leaflet to the luminal leaflet of the ER membrane, where it participates in the biosynthesis of glycosylphosphatidylinositol (GPI). GPI is a lipid glycoconjugate involved in post-translational modification of proteins. Can also translocate 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) (phosphatidylinositol or PI), as well as several other phospholipids (1,2-diacyl-sn-glycero-3-phosphocholine, 1,2-diacyl-sn-glycero-3-phosphoethanolamine), and N-acetylglucosaminylphosphatidylinositol (GlcNAc-PI) in vitro.

1. Wang, Y. et al. (2022) Proceedings of the National Academy of Sciences of the United States of America 119, e2115083119. PMID: 35344438

Note

For research use only.

Images

SDS-PAGE

SDS-PAGE for Anti-Human CLPTM1L Antibody (SAA1885)

References

Datasheet

Anti-Human CLPTM1L Recombinant Antibody (SAA1885).pdf

Download SDS PDF

Formula

Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)

Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.

Mass

Concentration

Volume

Molecular Weight *

g/mol

Formula

C₁ × V₁ = C₂ × V₂

Enter any 3 of the 4 values to solve for the unknown.

Stock Solution

C₁ (Stock Conc.)

V₁ (Stock Vol.)

Working Solution

C₂ (Working Conc.)

V₂ (Working Vol.)

Recombinant Proteins

Antibodies

Assay Kits

Anti-Human CLPTM1L Recombinant Antibody (SAA1885) (HA064013)

Overview

Images

References

Datasheet

SDS

Quick access

Contact Us